Abstract
ABSTRACT Adult acute myeloid leukemia (AML) is challengeable disease with poor heterogeneous outcome. Refining risk stratification is important for decision making and tailoring of therapy, multimerin-1(MMRN1) has been identified as a differentially expressed gene (DEG) in various cancers and it has been proposed as a possible cancer biomarker so, we aim to address prognostic value of Multimerin-1 in adult AML. This study was conducted on 240 AML, 40 healthy control, Taq man gene expression by RT PCR. Higher expression of Multimerin-1 was significant associated with failure of complete remission, relapse, short survival, highly significant association with minimal residual disease (MRD) positivity, molecular FLT3 (p 0.004, p.008) unfavorable cytogenetic (0.013). Cut off > 2.38 shows significantly short Overall Survival (OS), Disease-Free Survival (DFS). Finally, it could be independent poor risk for short survival; relapse thus may help in refine AML risk-stratification and tailoring therapy toward personalized medicine.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
